Bilirubin toxicity to human erythrocytes: A more sanguine view

Pediatrics

Volumn 120, Issue 1, 2007, Pages 175-178

  McDonagh, Antony F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN;

BILIRUBIN BLOOD LEVEL; CELL DESTRUCTION; CELL METABOLISM; CELL STRUCTURE; CORRELATION ANALYSIS; CRIGLER NAJJAR SYNDROME; CYTOTOXICITY; ERYTHROCYTE; EVIDENCE BASED MEDICINE; HEMOLYSIS; HUMAN; INCUBATION TIME; JAUNDICE; LIVER FUNCTION TEST; NONHUMAN; NOTE; PRIORITY JOURNAL;

ANIMALS; BILIRUBIN; ERYTHROCYTES; HEMOLYSIS; HUMANS; HYPERBILIRUBINEMIA, NEONATAL; INFANT, NEWBORN; JAUNDICE, NEONATAL; RATS; RATS, GUNN;

EID: 34447136697     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2007-0438     Document Type: Note

References (48)

1. Watson D. The absorption of bilirubin by erythrocytes. Clin Chim Acta. 1962;7:733-734
2. Cheung WH, Sawitsky A, Isenberg HD. The effect of bilirubin on the mammalian erythrocyte. Transfusion. 1966;6:475-486
3. Bratlid D. The effect of pH on bilirubin binding by human erythrocytes. Scand J Clin Lab Invest. 1972;29:453-459
4. Brodersen R. Supersaturation with bilirubin followed by colloid formation and disposition, with a hypothesis on the etiology of kernicterus. Scand J Clin Lab Invest. 1972;29:447-452
5. Brodersen R. Aqueous solubility, albumin binding, and tissue distribution of bilirubin. In: Ostrow JD, ed. Bile Pigments and Jaundice. New York, NY: Marcel Dekker, Inc; 1986:157-181
6. Brodersen R, Stern L. Aggregation of bilirubin in injectates and incubation media: its significance in experimental studies of CNS toxicity. Neuropediatrics. 1987;18:34-36
7. Brodersen R, Theilgaard J. Bilirubin colloid formation in neutral aqueous solution. Scand J Clin Lab Invest. 1969;24:395-398
8. Brites D, Silva R, Brito A. Effect of bilirubin on erythrocyte shape and haemolysis, under hypotonic, aggregating or non-aggregating conditions, and correlation with cell age. Scand J Clin Lab Invest. 1997;57:337-349
9. Brito MA, Silva R, Tiribelli C, Brites D. Assessment of bilirubin toxicity to erythrocytes: implication in neonatal jaundice management. Eur J Clin Invest. 2000;30:239-247
10. Brito MA, Silva RFM, Brites D. Bilirubin toxicity to human erythrocytes: a review. Clin Chim Acta. 2006;374:46-56
11. Crigler JF Jr, Najjar VA. Congenital familial nonhemolytic jaundice with kernicterus. Pediatrics. 1952;10:169-180
12. Arias IM. Chronic unconjugated hyperbilirubinemia without overt signs of hemolysis in adolescents and adults. J Clin Invest. 1962;41:2233-2245
13. Martin HP, Black O, Vanleeuwen G. Congenital nonhemolytic icterus: report of a case. Am J Dis Child. 1964;107:195-197
14. Sugar P. Familial nonhemolytic jaundice. Arch Intern Med. 1961;108:121-127
15. Lozzio BB, McDonald TP, Lange RD, Cawein MJ, Chernoff AI. Splenomegaly and haematologic disorders of the Gunn rat. Br J Haematol. 1970;19:543-554
16. Malloy HT, Lowenstein L. Hereditary jaundice in the rat. Can Med Assoc J. 1940;42:122-125
17. Brito MA, Silva RM, Matos DC, da Silva AT, Brites DT. Alterations of erythrocyte morphology and lipid composition by hyperbilirubinemia. Clin Chim Acta. 1996;249:149-165
18. Brown AK. Peculiarities of erythrocytes of the newborn. In: Sass-Kortsák A, ed. Kernicterus. Toronto, Ontario, Canada: University of Toronto Press; 1961:54-61
19. Tuffy P, Brown AK, Zuelzer WW. Infantile pyknocytosis: a common erythrocyte abnormality of the first trimester. AMA J Dis Child. 1959;98:227-241
20. Zannos-Mariolea L, Kattamis C, Paidoucis M. Infantile pyknocytosis and glucose-6-phosphate dehydrogenase deficiency. Br J Haematol. 1962;8:258-265
21. Keimowitz R, Desforges JF. Infantile pyknocytosis. N Engl J Med. 1965;273:1152-1154
22. Ackerman BD. Infantile pyknocytosis in Mexican-American infants. Am J Dis Child. 1969;117:417-423
23. Carpentieri U, Gustavson LP, Haggard ME. Pyknocytosis in a neonate: an unusual presentation of hereditary elliptocytosis. Clin Pediatr (Phila). 1977;16:76-78
24. Maxwell DJ, Seshadri R, Rumpf DJ, Miller JM. Infantile pyknocytosis: a cause of intrauterine haemolysis in 2 siblings. Aust N Z J Obstet Gynaecol. 1983;23:182-185
25. Dabbous IA, El Bahlawan L. Infantile pyknocytosis: a forgotten or a dead diagnosis? J Pediatr Hematol Oncol. 2002;24:507
26. Eyssette-Guerreau S, Bader-Meunier B, Garcon L, Guitton C, Cynober T. Infantile pyknocytosis: a cause of haemolytic anaemia of the newborn. Br J Haematol. 2006;133:439-442
27. Vest MF, Grieder HR. Erythrocyte survival in the newborn infant, as measured by chromium 51 and its relation to the postnatal serum bilirubin level. J Pediatr. 1961;59:194-199
28. Hsia DY, Goldbloom RB, Gellis SS. Studies on the relation of mechanical fragility of erythrocytes to physiological jaundice. AMA Am J Dis Child. 1953;86:505-509
29. Hsia DY, Goldbloom RB, Gellis SS. Studies of the mechanical fragility of erythrocytes. II. Relation to physiologic jaundice of the newborn infant. Pediatrics. 1954;13:24-29
30. Lin H, Eastman NJ. The behavior of intravenously injected bilirubin in newborn infants. Am J Obstet Gynecol. 1937;33:317-323
31. Thompson HE, Wyatt BL. Experimentally induced jaundice (hyperbilirubinemia). Arch Int Med. 1938;61:481-495
32. Weech AA, Vann D, Grillo RA. The clearance of bilirubin from the plasma: a measure of the excreting power of the liver. J Clin Invest. 1941;20:323-332
33. Kornberg A. Latent liver disease in persons recovered from catarrhal jaundice and in otherwise normal medical students as revealed by the bilirubin excretion test. J Clin Invest. 1942;21:299-308
34. Blaha G, Siam M, Lehner H. A circular dichroism (CD) study of the consecutive binding of serum albumin to bilirubin: possible implications for the bilirubin level. J Chem Soc Perkin Trans 2. 1997:2119-2124
35. Siam M, Blaha G, Lehner H. Maximum binding capacity of serum albumin for bilirubin is one, as revealed by circular dichroism. J Chem Soc Perkin Trans 2. 1998:853-856
36. a and aggregation of bilirubin: titrimetric and ultracentrifugation studies on water-soluble pegylated conjugates of bilirubin and fatty acids. Biochemistry. 2004;43:15617-15632
37. Brodersen R. Physical chemistry of bilirubin: binding to macromolecules and membranes. In: Heirwegh KPM, Brown SB, eds. Bilirubin. Boca Raton, FA: CRC Press, Inc; 1982:75-123
38. Petrich C, Krieg W, Voss HV, Göbel U. Effects of bilirubin on red cell metabolism. J Clin Chem Clin Biochem. 1977;15:77-80
39. Mireles LC, Lum MA, Dennery PA. Antioxidant and cytotoxic effects of bilirubin on neonatal erythrocytes. Pediatr Res. 1999;45:355-362
40. Brown AK. Bilirubin metabolism with special reference to neonatal jaundice. Adv Pediatr. 1962;12:121-187
41. Maisels MJ, Kring E. The contribution of hemolysis to early jaundice in normal newborns. Pediatrics. 2006;118:276-279
42. Zuelzer W. Introduction. In: Sass-Kortsák A, ed. Kernicterus. Toronto, Ontario, Canada: University of Toronto Press; 1961:39-40
43. Necheles TF, Rai US, Valaes T. The role of haemolysis in neonatal hyperbilirubinaemia as reflected in carboxyhaemoglobin levels. Acta Paediatr Scand. 1976;65:361-367
44. Lightner DA, McDonagh AF. Molecular mechanisms of phototherapy for neonatal jaundice. Acc Chem Res. 1984;17:417-424
45. Maisels MJ, Kring EA. Does intensive phototherapy produce hemolysis in newborns of 35 or more weeks gestation? J Perinatol. 2006;26:498-500
46. Feng BY, Shelat A, Doman TN, Guy RK, Shoichet BK. High-throughput assays for promiscuous inhibitors. Nat Chem Biol. 2005;1:146-148
47. McGovern SL, Caselli E, Grigorieff N, Shoichet BK. A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening. J Med Chem. 2002;45:1712-1722
48. Seidler J, McGovern SL, Doman TN, Shoichet BK. Identification and prediction of promiscuous aggregating inhibitors among known drugs. J Med Chem. 2003;46:4477-4486